NCT03987685 - Evaluate Oral Topotecan With HM30181A Monotherapy in Patients With Advanced Malignancies | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 19, 2018

Primary Completion Date

January 9, 2021

Study Completion Date

January 9, 2021

Conditions

Solid Tumor

Interventions

DRUG

Oratopo

Oral topotecan will be supplied in topotecan capsules and oral HM30181A-US tablets

Trial Locations (3)

HonorHealth Research Institute, Phoenix

Cancer Research UK Clinical Trials Unit- The Beatson West of Scotland Cancer Centre, Glasgow

Sir Bobby Robson Cancer Trials Research Centre, Freeman Hospital, Newcastle